Equity

Putnam VT Global Health Care Fund

NAV 1 $0.23(1.41%)
$16.51
As of 12/10/2025
Total Net Assets
$151.99M
As of 11/30/2025 (Updated Monthly)

Sign in to view documents

This feature is not available at your firm

Skipped to Overview Section Content

Overview

Fund Facts

Fund description

The fund seeks to provide a balanced investment composed of a well-diversified portfolio of stocks and bonds that produces both capital growth and current income. One of the pioneering mutual funds, it offers exposure to high-quality bonds to help manage volatility, and high-conviction stocks to drive relative returns.

Benchmark
MSCI World Health Care Index-NR
Fund Inception Date
04/30/1998
Share Class Inception Date
04/30/1998

Sales Charges, Expenses & Fees

As of 05/01/2025
Gross Expense Ratio2
0.98%
Net Expense Ratio2,3
0.98%
12b-1 Fee
0.25%

Identifiers

Ticker
Fund Number
5472
CUSIP Code
746896653
Bloomberg Code
VPHSIBV US

Geographic Focus

View portfolio section for additional info

As of 11/30/2025 % of Total (Updated Monthly)

United States78.52%
United Kingdom6.26%
Switzerland5.35%
Denmark4.15%
Japan1.83%

Additional Fund Info

Asset Class
Equity
Morningstar Category4
Health
Lipper Classification
Health/Biotechnology Funds
Investment Style
Sector

Sign in to view documents

Manager and Commentary

About the Team

Putnam Investments

Putnam Investments has been serving clients and shareholders for over 85 years. We manage a range of equity portfolios with a focus on stock-specific opportunities. Our approach — stock-driven rather than style-driven — is designed to offer consistent outperformance, regardless of the market environment. Our portfolios are fueled by a variety of independent views and perspectives, enhanced by fundamental research and ongoing dialogue and debate. We combine this with portfolio construction that aims to reduce broader macro exposures and manage downside risk.

Putnam Investments
[Mike Maguires avatar]

Managed Fund Since 2016

Portfolio Manager Profile
Years of Experience
Manager Location

Sign in to view documents

Skipped to Portfolio Section Content

Portfolio

Assets

As of11/30/2025 (Updated Monthly)

Total Net Assets
$151.99 Million

Positions

As of 11/30/2025 (Updated Monthly)

Number of Issuers
Fund
38

Portfolio Statistics

As of 11/30/2025 (Updated Monthly)

Price to Earnings (12-Month Forward)
Fund
21.50x
Weighted Average Market Capitalization (USD)
Fund
$311.22 Billion
Price to Book
Fund
6.29x

Sector Allocation

As of 11/30/2025 % of Total (Updated Monthly)

Sector % of Total
Benchmark
Pharmaceuticals
42.31%43.78%
Biotechnology
20.19%15.87%
Health Care Equipment
13.87%16.59%
Life Sciences Tools & Services
6.44%7.68%
Managed Health Care
5.06%5.19%
Health Care Distributors
5.03%2.91%
Health Care Services
2.39%3.19%
Health Care Facilities
2.14%1.19%
Health Care Supplies
0.84%2.93%
Health Care Technology
0.67%
Cash & Other Net Assets
1.74%

Chart

Bar chart with 2 data series.
The chart has 1 X axis displaying categories.
The chart has 1 Y axis displaying values. Data ranges from 0 to 43.78499.
End of interactive chart.

Holdings

As of 10/31/2025 (Updated Monthly)

ELI LILLY & CO SEDOL 2516152
JOHNSON & JOHNSON SEDOL 2475833
ABBVIE INC SEDOL B92SR70
UNITEDHEALTH GROUP INC SEDOL 2917766
ASTRAZENECA PLC SEDOL 0989529
NOVARTIS AG-REG SEDOL 7103065
THERMO FISHER SCIENTIFIC INC SEDOL 2886907
BOSTON SCIENTIFIC CORP SEDOL 2113434
ABBOTT LABORATORIES SEDOL 2002305
INTUITIVE SURGICAL INC SEDOL 2871301

Portfolio holdings are based on the total portfolio and are subject to change at any time. Holdings are provided for informational purposes only and should not be construed as a recommendation to purchase or sell any security. 

Skipped to Distributions Section Content

Distributions & Tax

Distribution Frequency
AnnuallyThis fund is an ex-Dividend fund
Capital Gain Distributions
March

Final composition of the current year’s distribution—income, capital gains and/or return of capital—are based on US tax rules and will be determined by February of the following year. For tax characterization of a distribution, such as return of capital and tax-exempt income, click on the “Tax Information” tab above.

Distributions Per Share
Distributions with future dates are estimates and those figures are not final

03/28/2025

Annually, a fund must distribute all realized capital gains net of realized losses, so the fund will not be subject to an entity level income tax. A fund’s capital gain distribution in a particular year may be a result of the disposition of holdings that appreciated in value during prior years. Thus, while the fund may gain or lose value over the course of a year, a capital gain distribution paid by the fund may not be indicative of current performance of the fund.

The distributable amount of net capital gains are paid on a per-share basis to all investors who hold shares of the fund on the record date of the distribution and are recognized by the shareholder for tax purposes as of the ex-date of the distribution, regardless of when the gains or losses arose in the fund. Net gains on holdings held long term by the fund would be distributed to shareholders as a long-term capital gain distribution no matter how long the shareholder has owned shares in the fund.

Refer to the fund’s annual report or statement of additional information for specific information regarding distributions.

Skipped to Documents Section Content

Documents

Regulatory Documents
Name Download Add to Cart
Annual Financial Statements and Other Information - Putnam VT Global Health Care FundMailed hardcopies unavailable.Download Document
Annual Report - Putnam VT Global Health Care Fund - Class IBDownload Document
Semi-Annual Report - Putnam VT Global Health Care Fund - Class IBDownload Document
Semi-Annual Financial Statements and Other Information - Putnam VT Global Health Care FundMailed hardcopies unavailable.Download Document
Prospectus - Putnam VT Global Health Care FundDownload Document
Summary Prospectus - Putnam VT Global Health Care FundDownload Document
Statement Of Additional Information - Putnam Variable TrustMailed hardcopies unavailable.Download Document
Fiscal Q1 Holdings - Putnam VT Global Health Care FundMailed hardcopies unavailable.Download Document
Fiscal Q3 Holdings - PUTNAM VARIABLE TRUSTDownload Document

Sign in to view documents

Risks

All investments involve risks, including possible loss of principal. International investments are subject to special risks, including currency fluctuations and social, economic and political uncertainties, which could increase volatility. These risks are magnified in emerging markets. Small- and mid-cap stocks involve greater risks and volatility than large-cap stocks. The investment style may become out of favor, which may have a negative impact on performance. To the extent the portfolio invests in a concentration of certain securities, regions or industries, it is subject to increased volatility. The portfolio is non-diversified and may invest in a relatively small number of issuers, which may negatively impact the performance and result in greater fluctuation in value. Derivative instruments can be illiquid, may disproportionately increase losses, and have a potentially large impact on performance. Active management does not ensure gains or protect against market declines. The manager may consider environmental, social and governance (ESG) criteria in the research or investment process; however, ESG considerations may not be a determinative factor in security selection. In addition, the manager may not assess every investment for ESG criteria, and not every ESG factor may be identified or evaluated. These and other risks are discussed in the fund’s prospectus.

Sign in to view documents

Past performance is no guarantee of future results. These portfolios are available as investment options under a variable annuity or variable life contract. Shares of the portfolios are offered only to insurance company separate accounts that fund certain variable annuity or life contracts. These portfolios may not be available in all states and may only be offered in certain variable products. Please refer to the prospectuses. Variable annuities are long-term, tax-deferred investment vehicles designed for retirement purposes. Gains from tax-deferred investments are taxable as ordinary income upon withdrawal. Withdrawals made prior to age 59 1/2 are subject to a 10% IRS penalty charge and/or surrender charges. Investments in a variable annuity are subject to market risks, including loss of principal. Guarantees are based on the claims-paying ability of the insurer.

VARIABLE ANNUITIES ARE SOLD BY PROSPECTUS ONLY. AN INVESTOR SHOULD CONSIDER THE INVESTMENT OBJECTIVES, RISKS, CHARGES AND EXPENSES OF THE INSURANCE CONTRACT AND THE UNDERLYING PORTFOLIO CAREFULLY BEFORE INVESTING. THE PROSPECTUSES CONTAIN THIS AND OTHER IMPORTANT INFORMATION ABOUT THE INSURANCE CONTRACT AND THE UNDERLYING PORTFOLIO. FOR A FREE PROSPECTUS ON THE UNDERLYING PORTFOLIO, PLEASE CLICK ON THE PROSPECTUS LINK. AN INVESTOR SHOULD READ THE PROSPECTUSES CAREFULLY BEFORE INVESTING.

You need Adobe Acrobat Reader to view and print PDF documents. Download a free version from Adobe's website.

Important data provider notices and terms available at www.franklintempletondatasources.com.

CFA® and Chartered Financial Analyst® are trademarks owned by CFA Institute.

Indexes are unmanaged and one cannot invest directly in an index. They do not reflect any fees, expenses or sales charges. 

The MSCI World Health Care Index is a free float-adjusted market capitalization-weighted index that is designed to measure the equity market performance of developed markets in the health care sector. Source: MSCI makes no warranties and shall have no liability with respect to any MSCI data reproduced herein. No further redistribution or use is permitted. This report is not prepared or endorsed by MSCI.
Net Returns (NR) include income net of tax withholding when dividends are paid.

Franklin Distributors, LLC. Member FINRA/SIPC. Putnam Investment is a Franklin Templeton company. Investment Products: NOT FDIC INSURED | NO BANK GUARANTEE | MAY LOSE VALUE.
Reports and other information about the fund are available on the EDGAR Database on the SEC's Internet site at www.sec.gov.    
FINANCIAL ADVISORS: Please note that not all share classes may be available for sale at your firm. Please call Franklin Templeton at (800) 530-2432 for more information.

Footnotes

  1. Net Asset Value - the amount per share you would receive if you sold shares that day. NAV Change indicates a change in the Net Asset Value from the previous business day.

  2. Gross Expense Ratio reflects the total annual operating expenses for the share class shown, prior to the deduction of any waiver or reimbursement. Actual expenses may be higher and may impact portfolio returns. Net Expense Ratio reflects total expenses after any fee waivers, implemented expense caps or reimbursements. If a fund has contractual fee waivers, expense caps and/or reimbursements, the expiration date can be found by clicking on the information button next to the net expense ratio. Additional amounts may be voluntarily waived and/or reimbursed and may be modified or discontinued at any time without notice. Expense ratios are as of the most recent prospectus or annual report.

  3. Net Expense Ratio represents the expense ratio applicable to investors. 

  4. The Morningstar Rating™ for funds, or “star rating”, is calculated for managed products with at least a three-year history, and subject to change monthly. Exchange-traded funds and open-ended mutual funds are considered a single population for comparative purposes. It is calculated based on a Morningstar Risk Adjusted Return measure that accounts for variation in a managed product’s monthly excess performance, placing more emphasis on downward variations and rewarding consistent performance. The top 10% of products in each product category receive 5 stars, the next 22.5% receive 4 stars, the next 35% receive 3 stars, the next 22.5% receive 2 stars, and the bottom 10% receive 1 star. The Overall Morningstar Rating is derived from a weighted average of the performance figures associated with its three-, five-, and 10-year (if applicable) Morningstar Rating metrics. The weights are: 100% three-year rating for 36-59 months of total return, 60% five-year rating/40% three-year rating for 60-119 months of total returns, and 50% 10-year rating/30% five-year rating/20% three-year rating for 120 or more months of total return. While the 10-year overall star rating formula seems to give the most weight to the 10-year period, the most recent three-year period actually has the greatest impact because it is included in all three rating periods. Ratings do not take into account the effects of sales charges and loads. Morningstar Rating is for the specified share class(es) only; other classes may have different performance characteristics.